Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia. - Wikidata - awgldk - TriplyDB

Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia.

Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia.

http://www.wikidata.org/entity/Q44612978

about

Treating refractory leukemias in childhood, role of clofarabine Childhood acute myeloid leukaemia Chimeric antigen receptor T cells for sustained remissions in leukemia Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma.Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan.Polyadenylation inhibition by the triphosphates of deoxyadenosine analogues.AAML0523: a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia.Clofarabine in leukemia.Deoxycytidine kinase modulates the impact of the ABC transporter ABCG2 on clofarabine cytotoxicity.NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantatio Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.Clofarabine: past, present, and future.Clofarabine: emerging role in leukemias.Clofarabine for the treatment of adult acute myeloid leukemia.Augmenting antitumor immune responses with epigenetic modifying agents.Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies.Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study.Report of a phase II study of clofarabine and cytarabine in de novo and relapsed and refractory AML patients and in selected elderly patients at high risk for anthracycline toxicity.Improving access to novel agents for childhood leukemia.Emerging pharmacotherapies for adult patients with acute lymphoblastic leukemia.Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant How I treat Langerhans cell histiocytosis.A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias.Biology and management of relapsed acute myeloid leukaemia.Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells.Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): a report from the Children's Oncology Group.Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation Emerging drugs for adult acute lymphoblastic leukaemia.Pyrimidine and purine analogues, effects on cell cycle regulation and the role of cell cycle inhibitors to enhance their cytotoxicity.Towards targeted therapy for infant acute lymphoblastic leukaemia.Cloretazine for the treatment of acute myeloid leukemia.Update on the therapy of highly aggressive non-Hodgkin's lymphoma.Chemotherapy for initial induction failures in childhood acute lymphoblastic leukemia: a Children's Oncology Group Study (POG 8764)French "real life" experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia.Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives Phase I and Phase II Objective Response Rates are Correlated in Pediatric Cancer Trials: An Argument for Better Clinical Trial Efficiency Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.Pediatric developmental therapies: interesting new drugs now in early-stage clinical trials.

P2860

Q24647279-2A5A1622-5EB4-489E-90AE-29B864232CB7 Q27005960-E6264EC7-1C34-4BCC-9A00-2694EF52EC00 Q29617588-95087827-0176-44B4-8843-A95DCCB482BE Q33383571-FB925D2F-502D-49A7-837C-A34BD99C61B5 Q33431558-FECE4D92-6435-4FD4-BAA3-4D87CE668410 Q33721126-062A7482-D7AA-4B81-BA8F-07F3AF63B81A Q34021009-2AB8B369-C9A7-49E1-A743-DB85E42A7DC9 Q34150263-A694030D-6B82-42B6-BB6C-2A6B841ED21E Q34159634-58351A0E-C17C-44F1-A861-735590D752DE Q34202277-916FD812-3517-4231-9889-DF702250C569 Q34648037-C5FE4B98-AB9D-4F81-AE40-1B7BDDA97B15 Q34679387-983742E7-D220-49B6-ACB2-42FA7EF5C0B0 Q34686726-93B92A8F-23D6-43F1-B97D-94BA1C8888E0 Q35000135-ABC04F93-4D3A-4BB8-9B89-4765D80FE263 Q35009273-21BA54DF-011D-4DCC-BA2C-667BFFBDF0B4 Q35048054-84F11606-B058-4534-B776-17533CD5557B Q35136563-129E7E2A-0D17-4705-BB0A-EE77FB689953 Q35136616-16496F24-B693-4A59-B485-641354A3969B Q35572057-4BD4A496-3C0C-4FD7-ADC3-D29752BF2071 Q35584427-24FBFF1C-EB94-41B3-B23A-617669240629 Q35688742-7BECC9B0-FD89-46E1-A9BB-EED2C9F3709C Q35740894-EB0568F2-6E3C-4C3A-9D62-CD84D7EE22E7 Q35770734-168BD3F0-ABD4-4A10-89A5-0C0173789A48 Q35820361-73554C88-E3DD-452E-B931-F58A9DB7592C Q35990683-6AE91E8E-6DB9-4917-9711-DC156271A28D Q36085026-F6820E80-47AC-43F1-AC36-33629E5129EF Q36094977-DE40D2AC-0ED3-43A1-B065-3BA7DDC9C6C6 Q36161733-65D27670-BB45-4917-99F3-16ECFE1CFE40 Q36176670-2A940FC2-5F50-421A-B7B8-5753C9D25DDD Q36219661-3D37E570-A857-4665-8348-E39CEF016478 Q36378036-272A253D-E20A-4D2D-BE58-EDC8744CE80F Q36381561-383F5FD4-453B-4172-9F45-BC1E500E393B Q36407434-692A0CDE-F329-4C4B-97C2-30976F05AE7A Q36521840-66163E1D-1205-4525-A05D-4B20A8593F47 Q36654178-B7397478-D47D-4762-8C66-50D43D86C9D8 Q36689775-EFE8D002-4DBA-44A8-A321-F32A0FD3EC2B Q36804215-E5B87A3A-0247-4F5D-BC7B-C79C68432994 Q37048013-6702444C-AF06-4F52-81E0-95D3281290A1 Q37064875-23D43B25-1F4B-44D9-8ECA-829CF5DDAFB9 Q37301320-38D80646-68CD-42AC-816E-BCFAB3C0BE20

P2860

Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia.

http://www.wikidata.org/entity/Q44612978

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Clofarabine, a novel nucleosid ...... tients with advanced leukemia.

@en

Clofarabine, a novel nucleosid ...... tients with advanced leukemia.

@nl

type

label

Clofarabine, a novel nucleosid ...... tients with advanced leukemia.

@en

Clofarabine, a novel nucleosid ...... tients with advanced leukemia.

@nl

prefLabel

Clofarabine, a novel nucleosid ...... tients with advanced leukemia.

@en

Clofarabine, a novel nucleosid ...... tients with advanced leukemia.

@nl

P1433

Q44612978-033B0C69-C37E-4339-8340-4462F9C8B657

P1476

Q44612978-99D95927-0910-4D56-BF4C-233924C76675

P2093

Q44612978-1DC9D0E8-D374-4E31-A491-7DB4A4C92E9C

Q44612978-209A7501-A54F-4092-855F-FB0E59127048

Q44612978-291C341A-EFE8-4D43-936F-60F712ADD8E6

Q44612978-8DBB0AA9-D191-492E-B059-658899FB9975

Q44612978-B6CC2519-D172-4FBA-93B3-F1EF75F2C9F2

Q44612978-BBD5C149-0519-4CF1-A4DE-DD3BB898DED4

Q44612978-D4E44B5C-14AD-425E-BDB4-A38A14BFFBB3

Q44612978-F6842617-36C3-4D7E-B634-76161228AC1F

P304

Q44612978-C22478C3-667C-4AF5-85CA-9271E1A61623

P31

Q44612978-F71BBBE0-5371-4323-8A38-E4DA14E33907

P356

Q44612978-094FF539-0C86-4584-BC9F-873BFFC7D347

P407

Q44612978-558EEB74-ED97-46CA-B414-EA0DEBB05B21

P433

Q44612978-BE8D716E-77A5-4895-B075-C361B173FBE1

P478

Q44612978-530DB29E-8D66-4D50-8747-8C3BD9356425

P50

Q44612978-710B725C-660F-4B48-96AC-CFDAD041713A

Q44612978-738730CF-3877-43DD-805B-051E6C39D714

Q44612978-AC82EB8F-7BCD-43D1-BD61-5CAF0DE937A4

P577

Q44612978-C7FFE267-FBC9-4423-ABBA-230663BCC914

P5875

Q44612978-FB5FE9B1-A388-4FD1-A38A-E2B1AA44D428

P698

Q44612978-AC5D2DE3-952D-447D-90F7-FCF2C41D60CF

P921

Q44612978-A9D7E4D2-7045-421E-AF66-DD0A512CF708

P356

BLOOD-2003-06-2122

P1433

P1476

Clofarabine, a novel nucleosid ...... tients with advanced leukemia.

@en

P2093

Irma Ramirez

http://www.w3.org/2001/XMLSchema#string

Ka Wah Chan

http://www.w3.org/2001/XMLSchema#string

Lisa McDonald

http://www.w3.org/2001/XMLSchema#string

Mark Brandt

http://www.w3.org/2001/XMLSchema#string

Michael Rytting

http://www.w3.org/2001/XMLSchema#string

Renee Madden

http://www.w3.org/2001/XMLSchema#string

Sima Jeha

http://www.w3.org/2001/XMLSchema#string

Varsha Gandhi

http://www.w3.org/2001/XMLSchema#string

P304

784-789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2003-06-2122

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Hagop Kantarjian

Michael J. Keating

William Plunkett

P577

2003-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9056633

http://www.w3.org/2001/XMLSchema#string

P698

14551141

http://www.w3.org/2001/XMLSchema#string

P921